Concepedia

Vânia Passos

VP

Statistics

Publications

5

Citations

117

H-Index

5

Active since

2018

Affiliations

Center for Experimental and Clinical Infection Research(Current)

Medizinische Hochschule Hannover

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

German Center for Infection Research

Charité - Universitätsmedizin Berlin

Vânia Passos is an author at Center for Experimental and Clinical Infection Research specializing in molecular virology, life sciences, and virology.

ORCID

Publications per year

2018–2021

5

Publications

5

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific

Veronika Lodermeyer, George Ssebyatika, Vânia Passos et al. · Journal of Virology · 2018 · 28 citations · Full text

, , +17

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue

Dorota Kmieć, Bengisu Akbil, Swetha Ananth et al. · PLoS Pathogens · 2018 · 26 citations · Full text

, , +16

Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor

Vânia Passos, Thomas Zillinger, Nicoletta Casartelli et al. · Journal of Virology · 2019 · 24 citations · Full text

, , +15

Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Sergej Franz, Fabian Pott, Thomas Zillinger et al. · Life Science Alliance · 2021 · 21 citations · Full text

, , +17

Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses

Zina M. Uckeley, Rebecca Moeller, Lars I. Kühn et al. · Molecular & Cellular Proteomics · 2019 · 18 citations · Full text

, , +17

1–5 of 5